The endoscopy team has since handled over a dozen additional cases. Creo Medical anticipates continued high usage from the trained physicians as they combat NHS waiting lists cost-effectively. SSD has already demonstrated cost savings of up to £10,000 per procedure compared to surgical alternatives, potentially benefiting hundreds of patients annually by providing less invasive options and reducing complications. The Royal Oldham is the 23rd NHS operation to use SSD, with twelve now high-volume users. Creo conservatively estimates that over 350 UK hospitals could benefit from implementing Speedboat Inject and SSD.